Multidrug-resistant Proteus rettgeri: an emerging problem

Insights

Multidrug-resistant Proteus rettgeri infections primarily affect the urinary tract, especially in neurology patients. Rising resistance to common antibiotics necessitates exploring alternatives like amikacin and cefoxitin.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Proteus rettgeri is an opportunistic pathogen.
  • The emergence of multidrug-resistant (MDR) strains poses a significant clinical challenge.
  • Urinary tract infections (UTIs) are common hospital-acquired infections.

Purpose of the Study:

  • To review a 6-year period of Proteus rettgeri infections.
  • To identify risk factors and trends associated with P. rettgeri UTIs.
  • To assess antimicrobial resistance patterns of P. rettgeri.

Main Methods:

  • Retrospective review of P. rettgeri infections over six years.
  • Comparison of UTI patients with a control group to identify risk factors.
  • Antimicrobial susceptibility testing using disc diffusion.

Main Results:

  • Ninety percent of infections were UTIs, with 50% occurring on a neurology ward.
  • Increased hospitalization, Foley catheter use, prior antibiotic exposure, and paraplegia were linked to P. rettgeri UTIs.
  • Progressive resistance to kanamycin, streptomycin, ampicillin, and gentamicin was observed.
  • Recent isolates showed high resistance to common antibiotics but susceptibility to amikacin, cefoxitin, and ticarcillin.

Conclusions:

  • Proteus rettgeri poses a growing threat, particularly for hospitalized neurology patients.
  • Risk factors for P. rettgeri UTIs include prolonged hospitalization and indwelling devices.
  • Emerging MDR strains necessitate careful antibiotic stewardship and consideration of alternative agents.

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...